Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial.

The Lancet. Child & adolescent health·2026
Same author

Moving beyond puberty: Listening to lived experience to expand sexual and reproductive healthcare for adults with muscular dystrophy.

Journal of neuromuscular diseases·2026
Same author

Caring for Gender Diverse Youth With Duchenne Muscular Dystrophy: A Multisite Case Series.

Pediatric neurology·2026
Same author

Loss of ambulation in SMA III at the time of disease-modifying treatments: an international study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.

Nature medicine·2026
Same author

Advancing treatment of spinal muscular atrophy through inhibition of the myostatin signaling pathway.

Expert review of neurotherapeutics·2026

Related Experiment Video

Updated: May 23, 2026

Performing In Vivo and Ex Vivo Electrical Impedance Myography in Rodents
05:44

Performing In Vivo and Ex Vivo Electrical Impedance Myography in Rodents

Published on: June 8, 2022

Multifrequency Electrical Impedance Myography Enhanced with Machine Learning for Screening Patients with

Buket Sonbas-Cobb1,2, Seward B Rutkove1, Baoguo Wei3

  • 1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Annals of Biomedical Engineering
|May 22, 2026
PubMed
Summary

Machine learning-enhanced electrical impedance myography (EIM) shows promise for screening neuromuscular disease. This non-invasive method accurately identifies individuals with muscle disorders, potentially improving early diagnosis.

Keywords:
Electrical impedance myography (EIM)Machine learning (ML)Muscle strength predictionNeuromuscular disorders

More Related Videos

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
04:30

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models

Published on: March 8, 2024

Related Experiment Videos

Last Updated: May 23, 2026

Performing In Vivo and Ex Vivo Electrical Impedance Myography in Rodents
05:44

Performing In Vivo and Ex Vivo Electrical Impedance Myography in Rodents

Published on: June 8, 2022

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
04:30

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models

Published on: March 8, 2024

Area of Science:

  • Biomedical Engineering
  • Neurology
  • Machine Learning Applications

Background:

  • Neuromuscular diseases require accurate and accessible diagnostic tools.
  • Surface electrical impedance myography (EIM) offers a non-invasive method for muscle assessment.
  • Machine learning (ML) can enhance the analytical capabilities of EIM data.

Purpose of the Study:

  • To evaluate surface EIM combined with ML as a novel office-based screening tool for neuromuscular disease.
  • To assess the diagnostic performance of ML-enhanced EIM in distinguishing individuals with and without neuromuscular disorders.

Main Methods:

  • Performed multifrequency EIM on 119 adults and 111 children across 3158 muscle measurements.
  • Utilized feature engineering and classification algorithms on multifrequency EIM data.
  • Employed nested cross-validation and majority voting for performance assessment and aggregation.

Main Results:

  • ML-enhanced EIM achieved 84% accuracy and 88.1% sensitivity in adults, and 93% accuracy and 94.6% sensitivity in children.
  • Multifrequency EIM features significantly improved classification performance compared to single-feature analyses.
  • EIM-based regression predicted muscle strength with R²=0.49, outperforming single-frequency correlations.

Conclusions:

  • Machine learning-enhanced EIM effectively distinguishes individuals with neuromuscular disease from healthy controls.
  • The technology shows potential as a convenient, office-based screening tool for neuromuscular conditions.
  • Further validation in larger populations is recommended to advance EIM for clinical screening.